Clinical Trials Directory

Trials / Completed

CompletedNCT02540759

Effect of Dose of Buglossoides Oil on EPA Accrual and on the Inflammatory Response

Study of the Effect of Dose of Buglossoides Arvensis Oil on Eicosapentaenoic Acid Accrual and on the Inflammatory Response

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
88 (actual)
Sponsor
Réseau de Santé Vitalité Health Network · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The effect of various doses of Buglossoides oil on the accrual of eicosapentaenoic acid (EPA) in blood and circulating cells will be investigated.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBuglossoides oil
DIETARY_SUPPLEMENTHigh Oleic Sunflower Oil

Timeline

Start date
2015-09-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2015-09-04
Last updated
2016-03-11

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02540759. Inclusion in this directory is not an endorsement.